Europe — EMA

Oxaliplatino Hikma

Oxaliplatin, the active ingredient in Oxaliplatino Hikma, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatino Hikma, is a platinum‑based chemotherapy agent presented as a unknown strength/unknown form for intravenous use. It treats colorectal cancer and is used in adult oncology patients. GNH USA supplies Oxaliplatino Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oxaliplatino Hikma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Oxaliplatin used for?

Oxaliplatin is a platinum‑based chemotherapy drug that interferes with DNA replication in several gastrointestinal malignancies.

- Colorectal cancer: improves the overall response rate when combined with fluorouracil and leucovorin. - Gastric cancer: used in combination regimens that aim to increase the tumor‑shrink response. - Pan‑Pan disease by

What are the side effects of Oxaliplatin?

The ... … ... … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →